loading page

In silico identification of gene targets to enhance C12 fatty acid production in Escherichia coli
  • +5
  • Paul Matthay,
  • Kenneth Simoens,
  • Thomas Schalck,
  • Dorien Kerstens,
  • Bert Sels,
  • Natalie Verstraeten,
  • Kristel Bernaerts,
  • Jan Michiels
Paul Matthay
Vlaams Instituut voor Biotechnologie VIB-KU Leuven Center for Microbiology
Author Profile
Kenneth Simoens
KU Leuven
Author Profile
Thomas Schalck
Vlaams Instituut voor Biotechnologie VIB-KU Leuven Center for Microbiology
Author Profile
Dorien Kerstens
KU Leuven Center for Sustainable Catalysis and Engineering
Author Profile
Bert Sels
KU Leuven Center for Sustainable Catalysis and Engineering
Author Profile
Natalie Verstraeten
Vlaams Instituut voor Biotechnologie VIB-KU Leuven Center for Microbiology
Author Profile
Kristel Bernaerts
KU Leuven
Author Profile
Jan Michiels
Vlaams Instituut voor Biotechnologie VIB-KU Leuven Center for Microbiology

Corresponding Author:[email protected]

Author Profile

Abstract

The global interest in fatty acids is steadily rising due to their wealth of industrial potential ranging from cosmetics to biofuels. Unfortunately, certain fatty acids, such as monounsaturated C12, cannot be produced cost and energy-efficiently using conventional methods. Biosynthesis of fatty acids using microorganisms can overcome this drawback. However, rewiring a microbe’s metabolome for increased production remains challenging. To overcome this, sophisticated genome-wide metabolic network models have become available. These models predict the effect of genetic perturbations on the metabolism, thereby serving as a guide for metabolic pathways optimization. In this work, we used constraint-based modeling in combination with the algorithm Optknock to identify gene deletions in Escherichia coli that improve the C12 fatty acid production. Nine gene targets were identified that, when deleted, were predicted to increase C12 titers. Targets play a role in anaplerotic reactions, amino acid synthesis, carbon metabolism and cofactor-balancing. Subsequently, we constructed the corresponding (combinatorial) deletion mutants to validate the in silico predictions in vivo. Our highest producer (Δ maeB Δ ndk Δ pykA) reaches a titer of 6.7 mg/L, corresponding to a 7.5-fold increase in C12 fatty acid production. This study demonstrates that model-guided metabolic engineering is a useful tool to improve C12 fatty acid production.